BioLineRx (BLRX) Revenue (2018 - 2026)
BioLineRx (BLRX) reported Revenue of $294,000 for the quarter ended Jun 30, 2026, down 3.3% from $304,000 a year earlier.
Powered by 
Analysis
BioLineRx (BLRX) Revenue (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, BioLineRx's Revenue came in at $1.22 million, down 92.9% year-over-year; for the year ended Dec 31, 2025, it came in at $1.18 million, down 95.9% from the prior year.
- By year, Revenue came in at $28.94 million in the year ended Dec 31, 2024 (+502.9%) and $4.8 million in the year ended Dec 31, 2023.
- Five-year quarterly Revenue spans a low of $194,000 in the quarter ended Dec 31, 2025 and a high of $11.75 million in the quarter ended Dec 31, 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 15.03 Bn |
| 10 | BioLineRx | 9.10 Mn | -67.42 Mn | 235,000.00 | 294,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 294,000.00 |
| Dec 31, 2025 | 194,000.00 |
| Sep 30, 2025 | 427,000.00 |
| Jun 30, 2025 | 304,000.00 |
| Mar 31, 2025 | 255,000.00 |
| Dec 31, 2024 | 11.75 Mn |
| Sep 30, 2024 | 4.94 Mn |
| Jun 30, 2024 | 5.39 Mn |
| Mar 31, 2024 | 6.86 Mn |
| Dec 31, 2022 | -2.40 Mn |
| Dec 31, 2021 | -1.78 Mn |
| Sep 30, 2021 | 330,000.00 |
| Jun 30, 2021 | -159,000.00 |
| Mar 31, 2021 | 392,000.00 |
| Dec 31, 2020 | -2.88 Mn |
| Sep 30, 2020 | 636,000.00 |
| Jun 30, 2020 | -404,000.00 |
| Mar 31, 2020 | 458,000.00 |
| Dec 31, 2019 | -3.63 Mn |
| Sep 30, 2019 | 817,000.00 |
API Access
BioLineRx Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();